Fetuin-A and thyroxin binding globulin predict rituximab response in rheumatoid arthritis patients with insufficient response to anti-TNFα. [electronic resource]
- Clinical rheumatology Sep 2020
- 2553-2562 p. digital
Publication Type: Journal Article
1434-9949
10.1007/s10067-020-05030-6 doi
Antirheumatic Agents--therapeutic use Arthritis, Rheumatoid--drug therapy Humans Proteomics Rituximab--therapeutic use Thyroxine--therapeutic use Thyroxine-Binding Globulin Treatment Outcome alpha-2-HS-Glycoprotein--therapeutic use